This one slipped by me in August, but was called to my attention in Hana's quarterly SEC filing, thus:
. . . .Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care. . . announced the appointment of Robert (Bob) Spiegel, M.D., FACP, to the Company's Board of Directors. Dr. Spiegel was employed at Schering Plough for 26 years where he was deeply involved in clinical research culminating with his position as Chief Medical Officer. . . .
Dr. Spiegel joined Schering Plough in 1983 as the first Director for Oncology clinical research and served as Chairman of the Oncology Development Team for 10 years. He served as Vice President of Clinical Research, then Senior Vice President of Worldwide Clinical Research, before being appointed Chief Medical Officer in 1998, a post he held until 2009. . . .
We'll watch and see -- over time -- how Hana's oncology candidates do.
No comments:
Post a Comment